2PCP

ANTIBODY FAB COMPLEXED WITH PHENCYCLIDINE


Sequence Similarity Clusters for the Entities in PDB 2PCP

Entity #1 | Chains: A,C
IMMUNOGLOBULIN protein, length: 216 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name
100 % 1 1 54066
95 % 75 171 206
90 % 80 181 190
70 % 815 2583 2
50 % 2125 6684 1
40 % 2126 6685 1
30 % 2141 6732 1
Entity #2 | Chains: B,D
IMMUNOGLOBULIN protein, length: 215 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name
100 % 1 1 54067
95 % 1 1 36547
90 % 1 1 34918
70 % 1017 3198 1
50 % 2126 6684 1
40 % 2127 6685 1
30 % 2142 6732 1

Instructions

In the table for each entity, view a list of similar sequences by selecting the link associated with the percentage cutoff.



View more detailed documentation on the redundancy reduction and sequence clustering procedure used by RCSB PDB.

You can also use the structure comparison tool to compare any 2 given structures


ACTION - (A) Select for download / view details OR (B) Select two chains for comparison
Rank PDB ID Entity ID Chains Description Details Taxonomy EC Number
1 4NZU 1 L 13PL heavy chain Fab 9606
2 4NZU 2 H 13PL light chain Fab 9606
3 1MJU 1 L IMMUNOGLOBULIN MS6-12 Fab fragment, LIGHT CHAIN 10090
4 1MJU 2 H IMMUNOGLOBULIN MS6-12 Fab fragment, HEAVY CHAIN 10090
5 4TRP 1 H Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
6 4TRP 2 L Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
7 1MEX 1 L Fab 29G12 light chain 10090
8 1MEX 2 H Fab 29G12 heavy chain 10090
9 3D9A 2 L Light Chain of HyHel10 Antibody Fragment (Fab) 10090
10 3D9A 3 H Heavy Chain of HyHel10 Antibody Fragment (Fab) 10090
11 4BUH 1 A, B CLONE M0418 SCFV 9606
12 3TV3 1 L PGT128 light chain, Ig lambda-2 chain C regions PGT128 light chain 9606
13 3TV3 2 H PGT128 heavy chain, Ig gamma-1 chain C region PGT128 heavy chain 9606
14 1NCW 1 L IMMUNOGLOBULIN IGG2A Antibody FAB fragment 4C6, light chain 10090
15 1NCW 2 H IMMUNOGLOBULIN IGG2A Antibody FAB fragment 4C6, heavy chain 10090
16 6UCF 1 L N123-VRC34_pI4 light chain 9606
17 6UCF 2 H N123-VRC34_pI4 heavy chain 9606
18 5YD4 1 A, C, E, G scFv 4B08 10090
19 5YD3 1 A, C, E, G scFv 4B08 10090
20 6OC7 1 H Heavy chain of HMP42 Fab 9606
21 6OC7 2 L Light chain for HMP42 Fab 9606
22 5UD9 1 H Fab heavy chain 9606
23 5UD9 2 L Light chain 9606
24 4P48 1 A Antibody scFv 180 9031
25 6DDM 1 A Anti-MICA Fab fragment light chain clone 1D5 10090
26 6DDM 3 B Anti-MICA Fab fragment heavy chain clone 1D5 10090
27 5TY6 1 H VRC 315 13-1b02 Fab Heavy chain 9606
28 5TY6 2 L VRC 315 13-1b02 Fab Light chain 9606
29 2XZC 1 H FAB A.17 HEAVY CHAIN 9606
30 2XZC 2 L FAB A.17 LIGHT CHAIN 9606
31 2XKN 1 A, C ANTI-EGFR ANTIBODY 7A7 FAB FRAGMENT LIGHT CHAIN (IGG1), RESIDUES 1-223 10090
32 2XKN 2 B, D ANTI-EGFR ANTIBODY 7A7 FAB FRAGMENT HEAVY CHAIN (IGG1), RESIDUES 1-216 10090
33 6MEE 1 A, C antibody HEPC74 Heavy Chain 9606
34 6MEE 2 B, D antibody HEPC74 Light Chain 9606
35 6BJZ 1 H 5c8 Fab Heavy chain 9606
36 6BJZ 2 L 5c8 Fab Light chain 9606
37 6O3D 1 L PGZL1 FAB LIGHT CHAIN 9606
38 6O3D 2 H PGZL1 FAB HEAVY CHAIN 9606
39 5KVG 2 L ZV-67 Antibody Fab Light Chain 10090
40 5KVG 3 H ZV-67 Antibody Fab Heavy Chain 10090
41 5WCA 1 H VRC315 27-1C08 Fab Heavy chain 9606
42 5WCA 2 L VRC315 27-1C08 Fab Light chain 9606
43 4XCF 1 L 4E10 Fab light chain 9606
44 4XCF 2 H 4E10 Fab heavy chain 9606
45 5KVF 2 L ZV-64 Antibody Fab Light Chain 10090
46 5KVF 3 H ZV-64 Antibody Fab Heavy Chain 10090
47 1RUP 1 L immunoglobulin igg2a, heavy chain fab 10090
48 1RUP 2 H immunoglobulin igg2a, light chain fab 10090
49 3ESU 1 F Antibody 14b7* light chain and antibody 14b7* heavy chain linked with a synthetic (GGGGS)4 linker 10090
50 6O24 1 A 4498 Fab heavy chain 9606
51 6O24 2 B 4498 Kappa light chain 9606
52 1RUK 1 L immunoglobulin igg2a, light chain fab 10090
53 1RUK 2 H immunoglobulin igg2a, heavy chain fab 10090
54 5VXR 1 H MAb24 Variable Heavy Chain,MAb24 Variable Heavy Chain 10090
55 5VXR 2 L MAb24 Variable Light Chain,MAb24 Variable Light Chain 10090
56 6UCE 1 L N123-VRC34_pI3 light chain 9606
57 6UCE 2 H N123-VRC34_pI3 heavy chain 9606
58 5X08 1 H Fab 4E10 Heavy chain 9606
59 5X08 2 L Fab 4E10 Light chain 9606
60 6NB8 1 H S230 antigen-binding (Fab) fragment, heavy chain 9606
61 6NB8 2 L S230 antigen-binding (Fab) fragment, light chain 9606
62 6A76 1 L Light chain of the anti-human Robo1 antibody B5209B Fab 10090
63 6A76 2 H Heavy chain of the anti-human Robo1 antibody B5209B Fab 10090
64 6U1T 1 H antigen-binding (Fab) fragment, heavy chain 10090
65 6U1T 2 L antigen-binding (Fab) fragment, light chain 10090
66 6MEG 1 H antibody HEPC46 Heavy Chain 9606
67 6MEG 2 L antibody HEPC46 Light Chain 9606
68 5C2B 1 H scFv 3B4 9606
69 6O3K 1 L PGZL1.H4K3 light chain 9606
70 6O3K 2 H PGZL1.H4K3 heavy chain 9606
71 4XAW 1 L 4E10 Fab light chain 9606
72 4XAW 2 H 4E10 Fab heavy chain 9606
73 4P49 1 A Antibody scFv B8 9031
74 3N9G 1 H Fab fragment of MAb CR4354, heavy chain 9606
75 3N9G 2 L Fab fragment of MAb CR4354, light chain 9606
76 4TUL 1 H Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
77 4TUL 2 L Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
78 6TCR 1 H Omalizumab Fab Ser81Arg, Gln83Arg and Leu158Pro light chain mutant Omalizumab Fab heavy chain 9606
79 6TCR 2 L Omalizumab Fab Ser81Arg, Gln83Arg and Leu158Pro light chain mutant Omalizumab Fab Ser81Arg, Gln83Arg and Leu158Pro light chain mutant 9606
80 5UCB 1 H Fab Heavy Chain 9606
81 5UCB 2 L Fab Light Chain 9606
82 2VXV 1 H HUMAN IGG ABT-325 9606
83 2VXV 2 L HUMAN IGG ABT-325 9606
84 6QF9 1 A, B scFv 9606
85 6FRJ 1 H scFv-SM3 Although this structure is a ScFv, please follow the same numbering as shown in PDB entry 5OWP. 10090
86 4GXV 1 H, I Antibody 1F1, heavy chain 9606
87 4GXV 2 L, M Antibody 1F1, light chain 9606
88 2VXT 1 H MURINE IGG 125-2H 10090
89 2VXT 3 L MURINE IGG 125-2H 10090
90 6CR1 1 L Light chain of adalimumab EFab (VL-IgE CH2) 9606
91 6CR1 2 H Heavy chain of adalimumab EFab (VH-IgE CH2) 9606
92 1RUM 1 L immunoglobulin igg2a, light chain fab 10090
93 1RUM 2 H immunoglobulin igg2a, heavy chain fab 10090
94 2XZA 1 H FAB A.17 HEAVY CHAIN 9606
95 2XZA 2 L FAB A.17 LIGHT CHAIN 9606
96 2W60 1 A ANTI-CITRULLINATED COLLAGEN TYPE II FAB ACC4 10090
97 2W60 2 B ANTI-CITRULLINATED COLLAGEN TYPE II FAB ACC4 10090
98 5W24 1 L 5C4 Fab Light Chain 10090
99 5W24 2 H 5C4 Fab Heavy Chain 10090
100 4HPY 1 H CH59 Fab heavy chain 9606
101 4HPY 2 L CH59 Fab light chain 9606
102 3T65 1 B S25-2 FAB (IGG1K) heavy chain 10090
103 3T65 2 A S25-2 FAB (IGG1K) light chain 10090
104 5C6W 1 H, J Protein IGHV1-69-2,Ig lambda chain V-II region NIG-84 9606
105 4JG1 1 L Fab light chain 9606
106 4JG1 2 H Fab heavy chain 9606
107 6E65 1 L TB31F Fab light chain 9606
108 6E65 2 H TB31F Fab heavy chain 9606
109 3M8O 1 L IMMUNOGLOBULIN A1 LIGHT CHAIN Fab fragment 9606
110 3M8O 2 H IMMUNOGLOBULIN A1 HEAVY CHAIN Fab fragment 9606
111 5VF2 1 A scFv 2D10 10090
112 5I8C 1 A VRC34.01 Fab heavy chain 9606
113 5I8C 2 B VRC34.01 Fab light chain 9606
114 4O5L 1 L Fab F045-092 light chain 9606
115 4O5L 2 H Fab F045-092 heavy chain 9606
116 5MYX 1 A, C Fab c#24 light chain 10090
117 5MYX 2 B, D Fab c#24 heavy chain Pyroglutamate residue 1 (PCA) results from post-translational modification of original residue glutamine 1. 10090
118 3IFL 1 L 12A11 FAB antibody light chain 10090
119 3IFL 2 H 12A11 FAB antibody heavy chain 10090
120 5WK2 1 L M116 LIGHT CHAIN 9606
121 5WK2 2 H M116 HEAVY CHAIN FD 9606
122 3PP4 1 H GA101 Fab heavy chain 10090
123 3PP4 2 L GA101 Fab light chain 10090
124 3KDM 1 A, L Immunoglobulin light chain 9606
125 3KDM 2 B, H Immunoglobulin heavy chain 9606
126 5NIV 1 A Light chain of 5D3 Fab 10090
127 5NIV 2 B Heavy chain of 5D3 Fab 10090
128 6UG7 1 L ch28/11 Fab light chain 10090
129 6UG7 2 H ch28/11 Fab heavy chain 10090
130 5N4J 1 L LIGHT CHAIN 9606
131 5N4J 2 H HEAVY CHAIN the sequence provided include the cleavable tag 9606
132 2AJU 1 L ANTIBODY 7A1 FAB' IMMUNOGLOBULIN IGG1 KAPPA LIGHT CHAIN 10090
133 2AJU 2 H ANTIBODY 7A1 FAB' IMMUNOGLOBULIN IGG1 HEAVY CHAIN 10090
134 2AJV 1 L Antibody 7A1 Fab' IMMUNOGLOBULIN IGG1 KAPPA LIGHT CHAIN 10090
135 2AJV 2 H Antibody 7A1 Fab' IMMUNOGLOBULIN IGG1 HEAVY CHAIN 10090
136 5X4G 1 A 6H8 Fab heavy chain 10090
137 5X4G 2 B 6H8 Fab light chain 10090
138 3SY0 1 A S25-2 FAB (IGG1K) light chain 10090
139 3SY0 2 B S25-2 FAB (IGG1K) heavy chain 10090
140 4PTU 1 A Antibody pn132p2C05, light chain 9606
141 4PTU 2 B Antibody pn132p2C05, heavy chain 9606
142 4TPR 1 L If kappa light chain 10090
143 4TPR 2 H Fab heavy chain 10090
144 6HGU 1 A, H anti-APP-tag Fab heavy-chain 10090
145 6HGU 2 B, L anti-APP-tag Fab light-chain anti-APP-tag Fab heavy-chain 10090
146 4HS6 2 A, L MRCT10.v362 Fab light chain 9606
147 4HS6 3 B, H MRCT10.v362 Fab heavy chain 9606
148 3IFN 1 H 12A11 FAB antibody heavy chain 10090
149 3IFN 2 L 12A11 FAB antibody light chain 10090
150 5U3P 1 H DH511.4 Fab Heavy Chain 9606
151 5U3P 2 L DH511.4 Fab Light Chain 9606
152 6BLA 1 H AMM01 Fab Heavy chain 9606
153 6BLA 2 L AMM01 Fab Light chain 9606
154 4TOY 1 H 35O22 Fab Heavy chain 9606
155 4TOY 2 L 35O22 Fab Light chain 9606
156 4TUO 1 A, C Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
157 4TUO 2 B, D Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
158 3NPS 2 B S4 FAB HEAVY CHAIN 9606
159 3NPS 3 C S4 FAB LIGHT CHAIN 9606
160 5I4F 1 A scFv 2D10 10090
161 1RUR 1 L immunoglobulin 13G5, light chain fab 10090
162 1RUR 2 H immunoglobulin 13G5, heavy chain fab 10090
163 5ADO 1 H FAB A.17 HEAVY CHAIN 9606
164 5ADO 2 L FAB A.17 LIGHT CHAIN 9606
165 5WN9 1 H scFv 2D10 9606
166 4XC3 1 L 4E10 Fab light chain 9606
167 4XC3 2 H 4E10 Fab heavy chain 9606
168 1X9Q 1 A 4m5.3 anti-fluorescein single chain antibody fragment antibody binding fragment 9606
169 4M5Y 1 H, I Fab 5J8 heavy chain 9606
170 4M5Y 2 L, M Fab 5J8 light chain 9606
171 4TQE 1 L If kappa light chain 10090
172 4TQE 2 H Fab heavy chain 10090
173 5YY4 1 A scFv 4B08 10090
174 4ISV 1 A 1C2 FAB LIGHT CHAIN 10090
175 4ISV 2 B 1C2 FAB HEAVY CHAIN 10090
176 4XC1 1 L 4E10 FAB LIGHT CHAIN 9606
177 4XC1 2 H 4E10 FAB HEAVY CHAIN 9606
178 6Q19 1 L Fab lambda chain 9606
179 6Q19 2 H Fab heavy chain 9606
180 6PDR 1 L antibody vFP25.18 light chain 10090
181 6PDR 2 H antibody vFP25.18 heavy chain 10090
182 5VSI 1 H CH1/Ckappa Fab heavy chain 9606
183 5VSI 2 L CH1/Ckappa Fab light chain 9606
184 5ODB 1 A D10 Fab fragment - heavy chain not modeled residues are not visible in the electron density map the Fab fragment was prepared from a antibody chimera containing the variable domains of the human D10 mAb and the constant domains of mouse IgG2a heavy chain and Ig-lambda light chain 9606
185 5ODB 2 B D10 Fab fragment - light chain not modeled residues are not visible in the electron density map the Fab fragment was prepared from a antibody chimera containing the variable domains of the human D10 mAb and the constant domains of mouse IgG2a heavy chain and Ig-lambda light chain 9606
186 4CMH 2 B HEAVY CHAIN OF SAR650984-FAB FRAGMENT 10090
187 4CMH 3 C LIGHT CHAIN OF SAR650984-FAB FRAGMENT 10090
188 5JXA 1 H VRC03 Heavy chain 9606
189 5JXA 2 L VRC03 Light chain 9606
190 3QHZ 1 H, I Human monoclonal antibody del2D1, Fab Heavy Chain Fab Heavy Chain 9606
191 3QHZ 2 L, M Human monoclonal antibody del2D1, Fab Light Chain Fab Light Chain 9606
192 6QCU 1 L Light chain 9606
193 6QCU 2 H Heavy chain 9606
194 3UJI 1 L Light chain of anti-HIV-1 V3 monoclonal antibody 2558 9606
195 3UJI 2 H Fab region of the heavy chain of anti-HIV-1 V3 monoclonal antibody 2558 9606
196 3NTC 1 L Fab light chain 10090
197 3NTC 2 H Fab heavy chain 10090
198 4YNY 1 A, C Heavy chain of antigen binding fragment, Fab 10116
199 4YNY 2 B, D Light chain of antigen binding fragment, Fab 10116
200 4TUK 1 H Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
201 4TUK 2 L Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
202 4YO0 1 A, C Heavy chain of antigen binding fragment, Fab 10116
203 4YO0 2 B, D Light chain of antigen binding fragment, Fab 10116
204 6PBV 1 A, C Fab668 light chain 9606
205 6PBV 2 B, D Fab668 heavy chain 9606
206 6PZG 1 L NA-80 Fab light chain 9606
207 6PZG 2 H NA-80 Fab heavy chain 9606
208 6AZM 1 A, C 580 germline antibody, light chain Fragment: Fab 9606
209 6AZM 2 B, D 580 germline antibody, heavy chain Fragment: Fab 9606
210 6BE3 1 H Fab (F598) Heavy Chain 9606
211 6BE3 2 L Fab (F598) Light Chain 9606
212 4NWU 1 H APE1551 Ab Fab heavy chain 9606
213 4NWU 2 L APE1551 Ab Fab light chain 9606
214 3HC4 1 H IMMUNOGLOBULIN IGG1 FAB, HEAVY CHAIN 9606
215 3HC4 2 L IMMUNOGLOBULIN IGG1 FAB, LIGHT CHAIN 9606
216 5VZR 1 A, H G4 antibody heavy chain Fab fragment 10090
217 5VZR 2 B, L G4 antibody light chain Fab fragment 10090
218 2W9D 1 H ICSM 18-ANTI-PRP THERAPEUTIC FAB HEAVY CHAIN 10090
219 2W9D 2 L ICSM 18-ANTI-PRP THERAPEUTIC FAB LIGHT CHAIN 10090
220 5EWI 1 H VRC38.01 Heavy Chain 9606
221 5EWI 2 L VRC38.01 Light Chain 9606
222 6SVL 1 A, D, G, H, K, O Fab_heavy_chain 9606
223 6SVL 2 B, E, I, L, M, P Fab_light_chain 9606
224 5E2W 1 L AT8 LIGHT CHAIN 10090
225 5E2W 2 H AT8 HEAVY CHAIN 10090
226 5MYK 1 A Fab c#17 light chain 10090
227 5MYK 2 B Fab c#17 heavy chain 10090
228 4NZR 1 H PGT135 heavy chain Fab 9606
229 4NZR 2 L PGT135 light chain Fab 9606
230 5MYO 1 A, C Fab c#6 light chain 10090
231 5MYO 2 B, D Fab c#6 heavy chain 10090
232 4HBC 1 H Antigen Binding Fragment, Immunoglobulin IgG - Heavy Chain 9986
233 4HBC 2 L Antigen Binding Fragment, Immunoglobulin IgG - Light Chain 9986
234 4AEH 1 H FAB ANTIBODY, HEAVY CHAIN VARIABLE DOMAIN, RESIDUES 1-231 10090
235 4AEH 2 L FAB ANTIBODY, LIGHT CHAIN VARIABLE DOMAIN, RESIDUES 1-214 10090
236 5UEL 1 H 354NC102 Fab Heavy Chain 9606
237 5UEL 2 L 354NC102 Fab Light Chain 9606
238 3UZQ 1 A anti-dengue Mab 4E11 Single chain variable fragment 10090
239 6WIY 1 H Fab 54-1G05 heavy chain 9606
240 6WIY 2 L Fab 54-1G05 light chain 9606
241 2V17 2 H MONOCLONAL ANTIBODY FAB FRAGMENT MN423 DISULPHIDE BRIDGE BETWEEN L214 AND H137 IS REDUCED 10090
242 2V17 3 L MONOCLONAL ANTIBODY FAB FRAGMENT MN423 DISULPHIDE BRIDGE BETWEEN L214 AND H137 IS REDUCED 10090
243 4J6R 2 H HEAVY CHAIN OF ANTIBODY VRC23 9606
244 4J6R 3 L LIGHT CHAIN OF ANTIBODY VRC23 9606
245 5E2V 1 L AT8 LIGHT CHAIN 10090
246 5E2V 2 H AT8 HEAVY CHAIN 10090
247 5SY8 1 H 10E8 FAB HEAVY CHAIN 9606
248 5SY8 2 L 10E8 FAB LIGHT CHAIN 9606
249 5OCK 1 L Human ACPA E4 Fab fragment - Light chain the N-terminal glutamine is posttranslationally modified to pyroglutamic acid 9606
250 5OCK 2 H Human ACPA E4 Fab fragment - Heavy chain the N-terminal glutamine is posttranslationally modified to pyroglutamic acid 9606
251 5DD1 1 H ANTI-HIV ANTIBODY DH570 FAB HEAVY CHAIN 9544
252 5DD1 2 L ANTI-HIV ANTIBODY DH570 FAB LIGHT CHAIN 9544
253 5JUE 1 L light chain of UIC2 Fab 10090
254 5JUE 2 H heavy chain of UIC2 Fab 10090
255 5CIN 1 H FAB 4E10 HEAVY CHAIN 9606
256 5CIN 2 L FAB 4E10 LIGHT CHAIN 9606
257 5A2J 1 H SCFV-SM3 CONTAINS BOTH H AND L CHAINS OF SCFV-SM3, CONNECTEDBY A LINKER. CHAIN L RESIDUES ARE NUMBERED FROM 1000. RESIDUES 6-115,20-129 10090
258 5JR1 1 H 10E8 heavy chain 9606
259 5JR1 2 L 10E8 mature light chain 9606
260 6CA7 1 L PCT64_13C light chain 9606
261 6CA7 2 H PCT64_13C heavy chain 9606
262 5VF6 1 A single chain variable fragment 9031
263 3CFB 1 A, L BLUE FLUORESCENT ANTIBODY EP2-19G2-KAPPA LIGHT CHAIN FAB 10090
264 3CFB 2 B, H BLUE FLUORESCENT ANTIBODY EP2-19G2-IGG2B HEAVY CHAIN FAB 10090
265 3WII 1 L, M anti-human ROBO1 antibody B2212A Fab light chain 10090
266 3WII 2 H, I anti-human ROBO1 antibody B2212A Fab heavy chain 10090
267 6K4Z 1 A, B scFv of C6 The fusion protein of expression tags (residues -2-0), the light chain (residues 1-108), linker GGGGSGGGGSGGGGS (residues 501-515), and the heavy chain (residues 1001-1113) 10090
268 6MVL 2 H Antibody Fab fragment heavy chain 9606
269 6MVL 3 L Antibody Fab fragment light chain 9606
270 5OB5 2 H fAb Heavy chain 9606
271 5OB5 3 L fAb Light chain 9606
272 3BKJ 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090
273 3BKJ 2 H WO2 IgG2a Fab fragment Heavy Chain 10090
274 5I66 1 A 8B6 antibody, heavy chain 10090
275 5I66 2 B 8B6 antibody, light chain 10090
276 6QBC 1 H Anti-Mcl1 Fab Heavy Chain 9606
277 6QBC 2 L Anti-Mcl1 Fab Light Chain 9606
278 4JAM 1 A, H ANTIGEN BINDING FRAGMENT OF HEAVY CHAIN of CH103 9606
279 4JAM 2 B, L ANTIGEN BINDING FRAGMENT OF LIGHT CHAIN of CH103 9606
280 6BZY 1 H 22D11 Heavy Chain 10090
281 6BZY 2 L 22D11 Light Chain 10090
282 3QQ9 1 C, L 101F LIGHT CHAIN 10090
283 3QQ9 2 D, H 101F HEAVY CHAIN 10090
284 5TKK 2 H mouse antibody vFP5.01 heavy chain 10090
285 5TKK 3 L mouse antibody vFP5.01 light chain 10090
286 6PLH 1 A Fab 5G12 light chain 10090
287 6PLH 2 B Fab 5G12 heavy chain 10090
288 5FGB 1 A, B Anti-HCV E2 Fab HC84-1 light chain 9606
289 5FGB 2 C, E Anti-HCV E2 Fab HC84-1 heavy chain 9606
290 5W6C 1 H UCA Fab heavy chain 9606
291 5W6C 2 L UCA Fab light chain 9606
292 5I1K 1 L FAB LIGHT CHAIN 9606
293 5I1K 2 H FAB HEAVY CHAIN 9606
294 3OZ9 1 L Fab NC-1 kappa light chain 10090
295 3OZ9 2 H Fab NC-1 IgG2a heavy chain 10090
296 4JDV 1 A, H Fab heavy chain NIH45-46 Germ-line HEAVY CHAIN, IG GAMMA-1 CHAIN 9606
297 4JDV 2 B, L Fab light chain NIH45-46 Germ-line Light CHAIN, IG Kappa 9606
298 5V7U 1 L CBTAU-22.1 Fab light chain 9606
299 5V7U 2 H CBTAU-22.1 Fab heavy chain 9606
300 5UEA 1 A, H Fab Heavy Chain 9606
301 5UEA 3 B, L Fab Light Chain 9606
302 4AL8 2 H FAB 2H12 HEAVY CHAIN 9606
303 4AL8 3 L FAB 2H12 LIGHT CHAIN 9606
304 6LTG 1 A, C antibody Fab fragment H-chain 10090
305 6LTG 2 B, D antibody Fab fragment L-chain 10090
306 3G5Y 1 A 175 light chain 10090
307 3G5Y 2 B 175 heavy chain 10090
308 5NMV 1 L Fab light chain 10088
309 5NMV 2 H Fab heavy chain 10088
310 4N8C 1 H, I Heavy chain of monoclonal antibody 10090
311 4N8C 2 L, M Light chain of monoclonal antibody 10090
312 5AZ2 1 H anti-human epiregulin antibody 9E5 Fab heavy chain 10090
313 5AZ2 2 L anti-human epiregulin antibody 9E5 Fab light chain 10090
314 4HGW 1 A Antibody Fab fragment, light chain 10090
315 4HGW 2 B Antibody Fab fragment, heavy chain 10090
316 1NLB 1 L antibody 19D9D6 light chain 10090
317 1NLB 2 H antibody 19D9D6 heavy chain 10090
318 1C5C 1 L CHIMERIC DECARBOXYLASE ANTIBODY 21D8 THE CONSTANT DOMAIN (RESIDUES 103-214) IS FROM HUMAN SOURCE, AND THE VARIABLE DOMAIN (RESIDUES 1-102) IS FROM MURINE SOURCE FAB 10090
319 1C5C 2 H CHIMERIC DECARBOXYLASE ANTIBODY 21D8 THE CONSTANT DOMAIN (RESIDUES 109-230) IS FROM HUMAN SOURCE, AND THE VARIABLE DOMAIN (RESIDUES 1-108) IS FROM MURINE SOURCE FAB 10090
320 3VFG 1 L 3F8 Light Chain 10090
321 3VFG 2 H 3F8 Heavy Chain 10090
322 5TDN 1 A, C anti-HER2 Fab Light Chain 9606
323 5TDN 2 B, D anti-HER2 Fab Heavy Chain 9606
324 3QRG 1 L Fab light chain 9606
325 3QRG 2 H Fab heavy chain Fd fragment 9606
326 5M6A 1 A, B, C, D Bence-Jones light chain 9606
327 4LLY 1 A, C mutated Pertuzumab Fab heavy chain 9606
328 4LLY 2 B, D light chain Clambda 9606
329 4EBQ 1 H anti-Vaccinia D8L antigen monoclonal IgG2a antibody LA5, heavy chain Fab 10090
330 4EBQ 2 L anti-Vaccinia D8L antigen monoclonal IgG2a antibody LA5, light chain 10090
331 5EZI 1 H Fab c12 heavy chain 9606
332 5EZI 2 L Fab c12 Light chain 9606
333 4K23 1 H anti-uPAR antibody, heavy chain 10090
334 4K23 2 L anti-uPAR antibody, light chain 10090
335 3NCJ 1 L Fab15 Mut8 light chain 9606
336 3NCJ 2 H Fab15 Mut8 heavy chain 9606
337 3UO1 1 H ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 H CHAIN 10090
338 3UO1 2 L ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 L CHAIN 10090
339 4M1G 1 L Murine IgG2a A27D7 Light chain Fab domain 10090
340 4M1G 2 H Murine IgG2a A27D7 Heavy chain Fab domain 10090
341 5W05 1 L M59 FAB LIGHT CHAIN 10090
342 5W05 2 H M59 FAB HEAVY CHAIN FD 10090
343 2IPU 1 K, L IgG2a Fab fragment Heavy Chain 10090
344 2IPU 2 G, H IgG2a Fab fragment Light Chain Kappa 10090
345 3HC3 1 H IMMUNOGLOBULIN IGG1 FAB, LIGHT CHAIN 9606
346 3HC3 2 L IMMUNOGLOBULIN IGG1 FAB, HEAVY CHAIN 9606
347 4M61 1 A, C Fab A52 light chain 10090
348 4M61 2 B, D Fab A52 heavy chain 10090
349 5YE3 1 B 2A7D9 VH CH1 chain 10090
350 5YE3 2 A 2A7D9 L chain 10090
351 3BKM 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090
352 3BKM 2 H WO2 IgG2a Fab fragment Heavy Chain 10090
353 1UM5 1 L Antibody 21H3 L chain 10090
354 1UM5 2 H Antibody 21H3 H chain 10090
355 3QHF 1 H Human monoclonal antibody del2D1, Fab Heavy Chain Fab Heavy Chain 9606
356 3QHF 2 L Human monoclonal antibody del2D1, Fab Light Chain Fab Light Chain 9606
357 4NWT 1 L APE1531 Ab Fab light chain 9606
358 4NWT 2 H APE1531 Ab Fab heavy chain 9606
359 3WHX 1 A mAb Fab H fragment 10090
360 3WHX 2 B mAb Fab L fragment 10090
361 3NA9 1 L Fab15 light chain 9606
362 3NA9 2 H Fab15 heavy chain 9606
363 3BAE 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090
364 3BAE 2 H WO2 IgG2a Fab fragment Heavy Chain 10090
365 6RCO 1 A, C R5.004 heavy chain 9606
366 6RCO 2 B, D R5.004 light chain 9606
367 6VBO 1 L DH813 light chain 9606
368 6VBO 2 H DH813 heavy chain 9606
369 1NGZ 1 A Germline Metal Chelatase Catalytic Antibody, Light chain germline Fab fragment 10090
370 1NGZ 2 B Germline Metal Chelatase Catalytic Antibody, Heavy chain germline Fab fragment 10090
371 4LRI 1 A, B MSL-109 Light Chain 9606
372 4LRI 2 C, P MSL-109 Heavy Chain 9606
373 4ZTP 1 L Light chain of Fab fragment of rabbit monoclonal antibody R53 9986
374 4ZTP 2 H Heavy chain of Fab fragment of rabbit monoclonal antibody R53 9986
375 4JN2 1 A, L anti dabigatran Fab 10090
376 4JN2 2 B, H anti dabigatran Fab 10090
377 4XBE 1 L 4E10 FAB LIGHT CHAIN 9606
378 4XBE 2 H 4E10 Fab heavy chain 9606
379 1MJ8 1 L IMMUNOGLOBULIN MS6-126 Fab Fragment, LIGHT CHAIN 10090
380 1MJ8 2 H IMMUNOGLOBULIN MS6-126 Fab Fragment, HEAVY CHAIN 10090
381 6BE2 1 H Fab (F598) Heavy Chain 9606
382 6BE2 2 L Fab (F598) Light Chain 9606
383 4JFZ 1 L Fab light chain 9606
384 4JFZ 2 H Fab heavy chain 9606
385 6ARP 1 A, C Cetuximab mutant light chain,Uncharacterized protein 9606
386 6ARP 2 B, D Cetuximab mutant Fab heavy chain,Immunoglobulin gamma-1 heavy chain 9606
387 3WIF 1 A mAb Fab H fragment 10090
388 3WIF 2 B mAb Fab L fragment 10090
389 5U6A 1 A Light Chain 9606
390 5U6A 2 B Heavy Chain 9606
391 6K0Y 1 A Antibody Heavy Chain 9606
392 6K0Y 2 B Antibody Light Chain 9606
393 5KVD 2 L ZV-2 Antibody Fab Light Chain 10090
394 5KVD 3 H ZV-2 Antibody Fab Heavy Chain 10090
395 3MBX 1 L X836 LIGHT CHAIN 10090
396 3MBX 2 H X836 HEAVY CHAIN CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN, FD fragment 10090
397 3TWC 1 L PGT127 light chain, Ig lambda-2 chain C regions 9606
398 3TWC 2 H PGT127 heavy chain, Ig gamma-1 chain C region 9606
399 6APC 1 H Epididymis luminal protein 214 9606
400 6APC 2 L IGL@ protein 9606
401 4HHA 1 A Fab KE5 Fab fragment KE5 9606
402 4HHA 2 B Antibody KE5 AD-2S1 eptiope 9606
403 6FZQ 1 H scFv-1SM3,scFv-1SM3 10090
404 5A2K 1 H IG LAMBDA-1 CHAIN V REGION S43 RESIDUES 6-115,20-129 10090
405 4RGO 2 H 14G8 heavy chain Fab 10090
406 4RGO 3 L 14G8 light chain Fab 10090
407 5N7B 1 H Ig heavy chain V-III region J606,Ig lambda-1 chain V region S43 Please follow the numbering described in the PDB entry 5A2K 10090
408 5GRY 1 A, G diabody 9606
409 5UEK 2 H Fab 12E Heavy Chain 9606
410 5UEK 3 L Fab 12E Light Chain 9606
411 3NAA 1 L Fab15 Mut5 light chain 9606
412 3NAA 2 H Fab15 Mut5 heavy chain 9606
413 1Q0X 1 L Fab 9B1, light chain 10090
414 1Q0X 2 H Fab 9B1, heavy chain 10090
415 4R90 1 L Anti CD70 Llama glama Fab 27B3 Light chain 9844
416 4R90 2 H Anti CD70 Llama glama Fab 27B3 Heavy chain 9844
417 4XVT 2 H donor 45 45-VRC01.H01+07.O-863513/45-VRC01.L01+07.O-110653 (VRC07_1995) Heavy chain 9606
418 4XVT 3 L 45-VRC01.H01+07.O-863513/45-VRC01.L01+07.O-110653 (VRC07_1995) Light chain 9606
419 5IK3 1 A, C 1E03 Fab fragment heavy chain 9606
420 5IK3 2 B, D 1E03 Fab fragment light chain 9606
421 5NPH 2 H Heavy chain of Fab fragment derived from non-neutralizing antibody DAO5 10090
422 5NPH 3 L Light chain of Fab fragment derived from non-neutralizing antibody DAO5 10090
423 5XLI 1 a, b FabL 10090
424 5XLI 2 c, d FabH 10090
425 5IHZ 1 A, C, E, H 1E01 Fab fragment heavy chain 9606
426 5IHZ 2 B, D, F, L 1E01 Fab fragment light chain 9606
427 6DC4 1 H Fab AM22 Heavy Chain 9606
428 6DC4 2 L Fab AM22 Light Chain 9606
429 2R1X 1 A Fab, antibody fragment (IgG1k), light chain 10090
430 2R1X 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
431 5U3D 1 A MEMAB TRASTUZUMAB FAB LIGHT CHAIN I83E 9606
432 5U3D 2 B MEMAB TRASTUZUMAB FAB HEAVY CHAIN 9606
433 4WUK 1 H CH65 heavy chain 9606
434 4WUK 2 L CH65 light chain 9606
435 3MLY 1 L, M Human monoclonal anti-HIV-1 gp120 V3 antibody 3074 Fab light chain 9606
436 3MLY 2 H, I Human monoclonal anti-HIV-1 gp120 V3 antibody 3074 Fab heavy chain 9606
437 5U3O 1 H DH511.2_K3 Fab Heavy Chain 9606
438 5U3O 2 L DH511.2_K3 Fab Light Chain 9606
439 5JOP 1 D, L Fab 14.22 light chain 10090
440 5JOP 2 E, H Fab14.22 heavy chain 10090
441 4HPO 1 H CH58 Fab heavy chain 9606
442 4HPO 2 L CH58 Fab light chain 9606
443 6VLN 1 H 4498 Fab heavy chain 9606
444 6VLN 2 L 4498 Fab light chain 9606
445 5UKN 1 H DH522UCA Fab fragment heavy chain 9544
446 5UKN 2 L DH522UCA Fab fragment light chain 9544
447 6BHZ 1 H, I Trastuzumab Anti-HER2 Fab Heavy Chain 9606
448 6BHZ 2 L, M Trastuzumab Anti-HER2 Fab Light Chain D185A 9606
449 5IT2 1 H heavy chain 9606
450 5IT2 2 L light chain 9606
451 6MY4 1 A, H anti-VEGF-A Fab fragment bH1 heavy chain 9606
452 6MY4 2 B, L anti-VEGF-A Fab fragment bH1 light chain 9606
453 4POZ 1 C light chain of Fab fragment of 10B9 antibody 10090
454 4POZ 2 D heavy chain of Fab fragment of 10B9 antibody 10090
455 4F57 1 L Light chain of Fab of a neutralizing antibody L1 light chain of L1 9606
456 4F57 2 H Heavy chain of Fab of a neutralizing antibody L1 heavy chain of L1 9606
457 5KVE 2 L ZV-48 Antibody scFv 10090
458 5MO3 2 H Fab of monoclonal antibody, heavy chain 10090
459 5MO3 3 L Fab of monoclonal antibody, light chain 10090
460 6L8T 1 B, D, L Antibody light chain 9606
461 6L8T 2 A, C, H Antibody heavy chain 9606
462 5GZ0 1 A, C FM329 light chain 1383439
463 5GZ0 2 B, D FM329 heavy chain 1383439
464 6DW2 1 A 6078 Fab light chain 9606
465 6DW2 2 B 6078 Fab heavy chain 9606
466 6SS0 1 HHH, III Fab C0021181 heavy chain (IgG1) Amino acids are numbered according to the Kabat numbering scheme. 9606
467 6SS0 2 LLL, MMM Fab C0021181 light chain (IgG1) Amino acids are numbered according to the Kabat numbering scheme. Residue 10 would not be present in the Kabat scheme, but due to problems with non-continuous numbering in L-peptides, we included it. Therefore, residues 2-10 should be read as 1-9, per Kabat. 9606
468 6MG4 1 A, B JTO light chain 9606
469 6BQB 1 L MGG4 Fab light chain 9606
470 6BQB 2 H MGG4 Fab heavy chain 9606
471 4PUB 1 H DX-2930 HEAVY CHAIN 9606
472 4PUB 2 L DX-2930 LIGHT CHAIN 9606
473 6B14 1 H Heavy chain of Fab BL3-6S97N 10090
474 6B14 2 L Light chain of Fab BL3-6S97N 10090
475 5DD6 1 A, H ANTI-HIV ANTIBODY DH570.mut58 FAB HEAVY CHAIN 9544
476 5DD6 2 B, L ANTI-HIV ANTIBODY DH570.mut58 FAB LIGHT CHAIN 9544
477 3WIH 2 L, M anti-human ROBO1 antibody B2212A Fab light chain 10090
478 3WIH 3 H, I anti-human ROBO1 antibody B2212A Fab heavy chain 10090
479 5GS3 1 A, H diabody protein 9606
480 3CFC 1 H BLUE FLUORESCENT ANTIBODY EP2-19G2-IGG2B HEAVY CHAIN FAB 10090
481 3CFC 2 L BLUE FLUORESCENT ANTIBODY EP2-19G2-KAPPA LIGHT CHAIN FAB 10090
482 3V4U 1 H ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 H CHAIN 10090
483 3V4U 2 L ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 L CHAIN 10090
484 5VKD 2 H Fab Heavy Chain 9606
485 5VKD 3 L Fab light chain 9606
486 2R1Y 1 A Fab, antibody fragment (IgG1k), light chain 10090
487 2R1Y 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
488 5XHG 1 A, C polypeptide(L) 10090
489 5XHG 2 B, D polypeptide(H) 10090
490 4XMP 2 H HEAVY CHAIN OF ANTIBODY VRC08 9606
491 4XMP 3 L LIGHT CHAIN OF ANTIBODY VRC08 9606
492 3UYR 1 H antibody Fab heavy chain 10090
493 3UYR 2 L antibody Fab light chain 10090
494 3V0W 1 L WN1 222-5 Fab (IgG2a) light chain 10090
495 3V0W 2 H WN1 222-5 Fab (IgG2a) heavy chain 10090
496 5OCX 1 L Fab fragment anti-citrullinated protein antibody E4 - light chain N-terminal glutamine is posttranslationally modified to pyroglutamic acid produced as chimera of human E4 mAb variable domains and mouse IgG2a constant domains 9606
497 5OCX 2 H Fab fragment of anti-citrullinated protein antibody E4 - heavy chain unmodelled residues not visible in electron density produced as chimera of human mAb E4 variable domains and mouse IgG2a constant domains 9606
498 1YQV 1 L HyHEL-5 Antibody Light Chain IG*G1 FAB FRAGMENT (HY/HEL-5) 10090
499 1YQV 2 H HyHEL-5 Antibody Heavy Chain IG*G1 FAB FRAGMENT (HY/HEL-5) 10090
500 3OAZ 1 H, M Fab 2G12, heavy chain Fab 9606
501 3OAZ 2 K, L Fab 2G12, light chain 9606
502 2R2B 1 A Fab, antibody fragment (IgG1k), light chain 10090
503 2R2B 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
504 1ZAN 1 L Fab AD11 Light Chain 10116
505 1ZAN 2 H Fab AD11 Heavy Chain 10116
506 6CJK 1 A, C Immunoglobulin Fab light chain 9986
507 6CJK 2 B, D Immunoglobulin Fab heavy chain 9986
508 4N0Y 1 H IGH526 Heavy Chain 9606
509 4N0Y 2 L IGH526 Light Chain 9606
510 3V52 1 H ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 H CHAIN 10090
511 3V52 2 L ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 L CHAIN 10090
512 6OTC 2 H sFab H3 heavy chain 32630
513 6OTC 3 L sFab H3 light chain 32630
514 6Q1G 1 L H1244 Fab lambda chain 9606
515 6Q1G 2 H H1244 Fab heavy chain 9606
516 5MTH 1 A, H antibody Fab heavy chain 10090
517 5MTH 2 B, L antibody Fab light chain 10090
518 3GGW 1 A, C FAB F22-4 LIGHT CHAIN 10090
519 3GGW 2 B, D FAB F22-4 HEAVY CHAIN 10090
520 6O26 1 A 3246 Fab heavy chain 9606
521 6O26 2 B 3246 Fab light chain 9606
522 1RZF 1 L Fab E51 light chain 9606
523 1RZF 2 H Fab E51 heavy chain 9606
524 5ZMJ 1 H Heavy chain of a Fab fraction of human IgG P01857 (UniProt) is referred. 9606
525 5ZMJ 2 L Light chain of a Fab fraction of human IgG P0DOY2(UniProt) is referred. 9606
526 6MY5 1 A, H anti-VEGF-A Fab fragment bH1 heavy chain 9606
527 6MY5 2 B, L anti-VEGF-A Fab fragment bH1 light chain 9606
528 6WJ0 1 H Fab 54-4H03 heavy chain 9606
529 6WJ0 2 L Fab 54-4H03 light chain 9606
530 4KTE 1 H GE148 Heavy Chain Fab Fab fragment 9544
531 4KTE 2 L GE148 Light Chain Fab 9544
532 5I8O 1 H HMM5 antibody heavy chain 9606
533 5I8O 2 L HMM5 antibody light chain 9606
534 4OUO 1 A anti Bla g 1 scFv 9031
535 4JG0 1 L Fab light chain 9606
536 4JG0 2 H Fab heavy chain 9606
537 6LKT 1 A antibody Fab fragment H chain 10090
538 6LKT 2 B antibody Fab Fragment L-chain 10090
539 4YGV 1 A, F aDabi-Fab2a heavy chain 9606
540 4YGV 2 B, L aDabi-Fab2a light chain 9606
541 5U4R 1 A, H VRC 315 53-1A09 Fab Heavy chain 9606
542 5U4R 2 B, L VRC 315 53-1A09 Fab Light chain 9606
543 5ALC 1 H ANTI-TICAGRELOR FAB 72, HEAVY CHAIN 9606
544 5ALC 2 L ANTI-TICAGRELOR FAB 72, LIGHT CHAIN 9606
545 5U5F 1 A MEMAB TRASTUZUMAB FAB LIGHT CHAIN I83E 9606
546 5U5F 2 B MEMAB TRASTUZUMAB FAB HEAVY CHAIN 9606
547 3EO0 1 A, C GC-1008 Fab Light Chain 10090
548 3EO0 2 B, D GC-1008 Fab Heavy Chain 10090
549 5CIL 1 H FAB 4E10 HEAVY CHAIN 9606
550 5CIL 2 L FAB 4E10 LIGHT CHAIN 9606
551 6BI2 1 H, I Trastuzumab Anti-HER2 Fab Heavy Chain 9606
552 6BI2 2 L, M Trastuzumab Anti-HER2 Fab Light Chain 9606
553 5F3B 1 A, E RK35 Chimeric antibody heavy chain 10090
554 5F3B 2 B, F RK35 Chimeric antibody light chain 10090
555 6TCO 1 A, L Omalizumab Fab Leu158Pro light chain mutant Omalizumab Fab Leu158Pro light chain mutant 9606
556 6TCO 2 B, H Omalizumab Fab Leu158Pro light chain mutant Omalizumab Fab heavy chain 9606
557 4FQI 3 H antibody CR9114 heavy chain Fab 9606
558 4FQI 4 L antibody CR9114 light chain Fab Lambda 9606
559 6S5A 2 H anti P329G LALA Fab heavy chain 10090
560 6S5A 3 L anti P329G LALA Fab light chain 10090
561 4JHA 1 H D25 antigen-binding fragment heavy chain 9606
562 4JHA 2 L D25 light chain 9606
563 6SS5 1 HHH Fab C0020187 heavy chain (IgG1) Amino acids are numbered according to the Kabat numbering scheme. 9606
564 6SS5 2 LLL Fab C0020187 light chain (IgG1) Amino acids are numbered according to the Kabat numbering scheme. Residue 10 would not be present in the Kabat scheme, but due to problems with non-continuous numbering in L-peptides, we included it. Therefore, residues 2-10 should be read as 1-9, per Kabat. 9606
565 6B9Z 1 A Trastuzumab Fab light chain 10090
566 6B9Z 2 B Trastuzumab Fab heavy chain CSO is partially oxidized cysteine 10090
567 3MCL 1 L C706 MONOCLONAL LIGHT CHAIN CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN 10090
568 3MCL 2 H C706 MONOCLONAL HEAVY CHAIN FD fragment of the heavy chain, CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN 10090
569 4PTT 1 A Antibody pn132p2C05, light chain 9606
570 4PTT 2 B Antibody pn132p2C05, heavy chain 9606
571 5OD0 1 L Fab fragment of ACPA E4 - Light chain the Fab fragment was prepared from a chimeric antibody containing the variable domain of human ACPA E4 and constant domains of mouse IgG2b the N-terminal Gln is posttranslationally modified to pyroglutamic acid 2 C-terminal residues not visible in electron density and therefore not modelled 9606
572 5OD0 2 H Fab fragment of ACPA E4 - heavy chain the Fab fragment was prepared from a chimeric antibody containing the variable domain of human ACPA E4 and constant domains of mouse IgG2b the N-terminal Gln is posttranslationally modified to pyroglutamic acid residues not modeled are not visible in the electron density map 9606
573 5KVL 1 H Humanized 10G4 anti-Leukotriene C4 Immunoglobulin G (IgG) heavy chain Fab fragment 9606
574 5KVL 2 L Humanized 10G4 anti-Leukotriene C4 Immunoglobulin G (IgG) light chain 9606
575 5TDO 1 A, C anti-HER2 Fab Light Chain 9606
576 5TDO 2 B, D anti-HER2 Fab Heavy Chain 9606
577 8FAB 1 A, C IGG1-LAMBDA HIL FAB (LIGHT CHAIN) 9606
578 8FAB 2 B, D IGG1-LAMBDA HIL FAB (HEAVY CHAIN) 9606
579 5NHW 1 H anti-human ActRII Bimagrumab Fab heavy-chain C-terminal FLAG-His6 tag Fab heavy-chain 9606
580 5NHW 2 L anti-human ActRII Bimagrumab Fab light-chain Fab light-chain 9606
581 2ZPK 1 L, M IgG1-lambda P20.1 Fab (light chain) 10090
582 2ZPK 2 H, I IgG1-lambda P20.1 Fab (heavy chain) Variable and Constant region 10090
583 4DGV 1 H HCV1 Heavy Chain Fab 9606
584 4DGV 2 L HCV1 Light Chain 9606
585 6C5K 1 A, H IgG1 Fab Heavy Chain 10090
586 6C5K 2 B, L IgG1 Fab Light Chain (Kappa) 10090
587 2DQU 1 L IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
588 2DQU 2 H IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
589 5TH2 1 A, C cetuximab Fab, light chain 10090
590 5TH2 2 B, D cetuximab Fab, heavy chain 10090
591 5I8K 1 L HHH1 Fab Light chain 9606
592 5I8K 2 H HHH1 Fab Heavy chain 9606
593 4YDL 2 B, H HEAVY CHAIN OF ANTIBODY C38-VRC18.02 9606
594 4YDL 3 C, L LIGHT CHAIN OF ANTIBODY C38-VRC18.02 9606
595 6ULF 1 A 4498 Fab heavy chain 9606
596 6ULF 2 B 4498 Fab light chain 9606
597 3T4Y 1 A S25-2 FAB (IGG1K) LIGHT CHAIN 10090
598 3T4Y 2 B S25-2 FAB (IGG1K) HEAVY CHAIN 10090
599 1YNL 1 L Ig gamma light chain 10090
600 1YNL 2 H Ig gamma heavy chain 10090
601 5EPM 1 A, E Antibody Fab fragment heavy chain 10090
602 5EPM 2 B, F Antibody Fab fragment light chain 10090
603 2AJS 1 L Antibody 7A1 FAB' IMMUNOGLOBULIN IGG1 kappa light chain 10090
604 2AJS 2 H Antibody 7A1 FAB' IMMUNOGLOBULIN IGG1 HEAVY CHAIN 10090
605 3UMT 1 A scFv heavy chain and light chain 10090
606 6U8D 2 H Heavy chain of Fab HCV2 Heavy chain of Fab HCV2 9606
607 6U8D 3 L Light chain of Fab HCV2 Light chain of Fab HCV2 9606
608 3BZ4 1 A, C, E, G Fab F22-4 light chain 10090
609 3BZ4 2 B, D, F, H Fab F22-4 heavy chain 10090
610 6UC5 1 H Fab397 heavy chain 9606
611 6UC5 2 L Fab397 light chain 9606
612 6PEC 1 L antibody light chain 9544
613 6PEC 2 H antibody heavy chain 9544
614 4NUJ 1 A PGT152 light chain 9606
615 4NUJ 2 B PGT152 heavy chain 9606
616 3LIZ 2 L 4C3 monoclonal antibody Light Chain 10090
617 3LIZ 3 H 4C3 monoclonal antibody Heavy Chain 10090
618 1RUA 1 L immunoglobulin igg2a, light chain fab 10090
619 1RUA 2 H immunoglobulin igg2a, heavy chain fab 10090
620 3U2S 1 A, H PG9 heavy chain antigen-binding fragment 9606
621 3U2S 2 B, L PG9 light chain 9606
622 6PE7 1 H FAB Heavy Chain 9606
623 6PE7 2 L FAB Light chain 9606
624 5D6C 1 A, L 4497 antibody IgK (VL and CL) 9606
625 5D6C 2 B, H 4497 antibody IgG1 (VH and CH1) 9606
626 4GAG 1 H NEUTRALIZING ANTIBODY AP33 HEAVY CHAIN 10090
627 4GAG 2 L NEUTRALIZING ANTIBODY AP33 LIGHT CHAIN 10090
628 2R23 1 A Fab, antibody fragment (IgG1k), light chain 10090
629 2R23 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
630 4NUG 1 L PGT151 light chain 9606
631 4NUG 2 H PGT151 heavy chain 9606
632 7BZ5 2 H Heavy chain of B38 9606
633 7BZ5 3 L Light chain of B38 9606
634 3IU4 1 H chP3 Fab heavy chain 10090
635 3IU4 2 L chP3 Fab light chain 10090
636 3MNZ 2 A ANTI-HIV-1 ANTIBODY 13H11 LIGHT CHAIN mouse Fv,human Fc 10090
637 3MNZ 3 B ANTI-HIV-1 ANTIBODY 13H11 HEAVY CHAIN mouse Fv,human Fc 10090
638 6DC8 1 L IgG light chain 10090
639 6DC8 2 H IgG heavy chain 10090
640 6NYQ 1 L 1H3 Fab light chain 10090
641 6NYQ 2 H 1H3 Fab heavy chain 10090
642 3MLR 1 L Human monoclonal anti-HIV-1 gp120 V3 antibody 2557 Fab light chain 9606
643 3MLR 2 H Human monoclonal anti-HIV-1 gp120 V3 antibody 2557 Fab heavy chain 9606
644 1QYG 1 L FAB M82G2, LIGHT CHAIN 10090
645 1QYG 2 H FAB M82G2, HEAVY CHAIN 10090
646 6IAS 1 H Fab NKp46-1 heavy chain 32630
647 6IAS 2 L Fab NKp46-1 light chain 32630
648 1P7K 1 A, L antibody light chain FAB 10090
649 1P7K 2 B, H antibody heavy chain FAB 10090
650 6OBZ 1 A, H Heavy chain of FluA-20 Fab 9606
651 6OBZ 2 B, L Light chain of FluA-20 Fab, Immunoglobulin light chain 9606
652 3RVV 2 C 4C1 - light chain 10090
653 3RVV 3 D 4C1 - heavy chain 10090
654 5A2L 1 H SCFV-SM3 RESIDUES 6-115,20-129 10090
655 6GFE 2 L, M Immunoglobulin gamma-4 light chain 9606
656 3P0Y 2 H Fab DL11 heavy chain 9606
657 3P0Y 3 L Fab DL11 light chain 9606
658 4NPY 1 A, L germline PGT121 light chain Fab 9606
659 4NPY 2 B, H germline PGT121 heavy chain Fab 9606
660 6ANA 2 H LL2 Fab Heavy Chain 10090
661 6ANA 3 L LL2 Fab Light Chain 10090
662 5IBU 1 B, L 6652 Light Chain 9606
663 5IBU 2 G, H 6652 Heavy Chain 9606
664 5VPL 2 C 4C1 - LIGHT CHAIN 10090
665 5VPL 3 D 4C1 - HEAVY CHAIN 10090
666 6AOD 1 A FXIa Antibody FAB Light Chain 9606
667 6AOD 2 B FXIa Antibody FAB Heavy Chain 9606
668 5WCD 1 H VRC315 04-1D02 Fab Heavy chain 9606
669 5WCD 2 L VRC315 04-1D02 Fab Light chain 9606
670 2YPV 2 H FAB 12C1 10090
671 2YPV 3 L FAB 12C1 10090
672 6TCM 1 L Omalizumab Fab Omalizumab Fab light chain 9606
673 6TCM 2 H Omalizumab Fab Omalizumab Fab heavy chain 9606
674 4HH9 1 A, C Fab KE5, light chain KE5 Light chain 9606
675 4HH9 2 B, D Fab KE5, heavy chain KE5 Heavy Chain 9606
676 4JY5 1 L PGT122 light chain Fab 9606
677 4JY5 2 H PGT122 heavy chain Fab 9606
678 6ELE 1 A, H fAB heavy chain 9606
679 6ELE 2 B, L fAB light chain 9606
680 5UR8 1 A human immunoglobulin gamma, heavy chain Fd fragment 9606
681 5UR8 2 B human immunoglobulin gamma, kappa light chain 9606
682 6B5R 1 H CIS42 Fab Heavy chain 9606
683 6B5R 2 L CIS42 Fab Light chain 9606
684 3NAC 1 L Fab15 Mut7 light chain 9606
685 3NAC 2 H Fab15 Mut7 heavy chain 9606
686 5U5M 1 A MEMAB TRASTUZUMAB, LIGHT CHAIN 9606
687 5U5M 2 B MEMAB TRASTUZUMAB, HEAVY CHAIN 9606
688 2DQT 1 L IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
689 2DQT 2 H IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
690 1Q72 1 L Fab M82G2, Light chain 10090
691 1Q72 2 H Fab M82G2, Heavy chain 10090
692 6XCA 1 H C105 Heavy Chain 9606
693 6XCA 2 L C105 Light Chain 9606
694 4M1D 1 L, M Fab mAb 447-52D Light Chain 9606
695 4M1D 2 H, I Fab mAb 447-52D Heavy Chain 9606
696 6MNQ 2 H Ab DH727.2 heavy chain Fab fragment 9544
697 6MNQ 3 L Ab DH727.2 light chain 9544
698 1SEQ 1 L Monoclonal Antibody MNAC13 FAB Light Chain 10090
699 1SEQ 2 H Monoclonal Antibody MNAC13 FAB Heavy Chain 10090
700 4YHO 1 H aDabi-Fab3 heavy chain 9606
701 4YHO 2 L aDabi-Fab3 light chain 9606
702 6FZR 1 H scFv-SM3 Special processing instructions: Although this structure is a ScFv, please follow the same numbering as shown in PDB entry 5OWP. 10090
703 6NMT 1 A Fab 3 anti-SIRP-alpha antibody Variable Light Chain 9606
704 6NMT 2 B Fab 3 anti-SIRP-alpha antibody Variable Heavy Chain 9606
705 2R1W 1 A Fab, antibody fragment (IgG1k), light chain 10090
706 2R1W 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
707 3MO1 1 A ANTI-HIV-1 ANTIBODY 13H11 LIGHT CHAIN FUSION PROTEIN between mouse Fv and a human Fc 10090
708 3MO1 2 B ANTI-HIV-1 ANTIBODY 13H11 HEAVY CHAIN FUSION PROTEIN between mouse Fv and a human Fc 10090
709 4DGY 1 H HCV1 Heavy Chain Fab 9606
710 4DGY 2 L HCV1 Light Chain 9606
711 5EN2 1 A GD01 heavy chain 10090
712 5EN2 2 B GD01 light chain 10090
713 3T77 1 A S25-2 FAB (IGG1K) light chain 10090
714 3T77 2 B S25-2 FAB (IGG1K) heavy chain 10090
715 6P4Y 1 H 4A10 Fab heavy chain 10090
716 6P4Y 2 L 4A10 Fab light chain 10090
717 3MXW 2 L 5E1 light chain 9606
718 3MXW 3 H 5E1 heavy chain 9606
719 2V7N 1 A, C, E, G IMMUNOGLOBULIN LIGHT CHAIN SYNTHETIC GENE, DERIVED FROM PHAGE DISPLAY OF THE HUMAN COMBINATORIAL ANTIBODY LIBRARY (HUCAL) FAB FRAGMENT, RESIDUES 1-255 32630
720 2V7N 2 B, D, F, H IMMUNOGLOBULIN HEAVY CHAIN SYNTHETIC GENE, DERIVED FROM PHAGE DISPLAY OF THE HUMAN COMBINATORIAL ANTIBODY LIBRARY (HUCAL) FAB FRAGMENT, RESIDUES 1-259 32630
721 3EO9 1 L Efalizumab Fab fragment, light chain 9606
722 3EO9 2 H Efalizumab Fab fragment, heavy chain 9606
723 4ALA 2 H FAB 2H12 HEAVY CHAIN 10090
724 4ALA 3 L FAB 2H12 LIGHT CHAIN 10090
725 6N35 1 K, L Fab 2G12 light chain 9606
726 6N35 2 H, M Fab 2G12 heavy chain 9606
727 4F33 1 A, C, E, G MORAb-009 FAB light chain 10090
728 4F33 2 B, D, F, H MORAb-009 FAB heavy chain 10090
729 3C6S 1 A, C, E, G Fab F22-4 light chain 10090
730 3C6S 2 B, D, F, H Fab F22-4 heavy chain 10090
731 5WUV 1 L light chain 9606
732 5WUV 2 H heavy chain 9606
733 4Z8F 1 H S1-15 Fab (IgG2b) heavy chain 10090
734 4Z8F 2 L S1-15 Fab (IgG2b kappa) light chain 10090
735 3OKL 1 A S25-39 Fab (IgG1k) light chain 10090
736 3OKL 2 B S25-39 Fab (IgG1k) heavy chain 10090
737 4JM4 1 H PGT 135 Heavy Chain Fab 9606
738 4JM4 2 L PGT 135 Light Chain Fab 9606
739 2HWZ 1 L Immunoglobulin Fab light chain Humanized mouse antibody MEDI-493 Anti-respiratory syncytial virus antibody 10090
740 2HWZ 2 H Immunoglobulin Fab heavy chain Humanized mouse antibody MEDI-493 Anti-respiratory syncytial virus antibody 10090
741 5YE4 1 A, C 1A9D7 VH CH1 chain 10090
742 5YE4 2 B, D 1A9D7 L chain 10090
743 6B0G 1 C 1245 Antibody, Light Chain 9606
744 6B0G 2 D 1245 Antibody, Heavy Chain 9606
745 5TDP 1 A, C anti-HER2 Fab Light Chain 9606
746 5TDP 2 B, D anti-HER2 Fab Heavy Chain 9606
747 1ZEA 1 L monoclonal anti-cholera toxin IGG1 KAPPA antibody, L chain 10090
748 1ZEA 2 H monoclonal anti-cholera toxin IGG1 KAPPA antibody, H chain 10090
749 6BAH 1 A Trastuzumab Fab light chain,Immunoglobulin kappa constant 10090
750 6BAH 2 B Trastuzumab Fab heavy chain,IGH@ protein 10090
751 6D0X 1 A 2140 Antibody, heavy chain 9606
752 6D0X 2 B 1210 Antibody, light chain 9606
753 6UUD 1 H 5D5 Antibody Fab, heavy chain 10090
754 6UUD 2 L 5D5 Antibody Fab, light chain 10090
755 6BE4 1 H Fab (F598) Heavy Chain 9606
756 6BE4 2 L Fab(F598) Light Chain 9606
757 5TPP 1 L DH270.5 Fab heavy chain 9606
758 5TPP 2 H DH270.5 Fab light chain 9606
759 5L88 1 H Anti-afamin antibody N14, Fab fragment, heavy chain 10090
760 5L88 2 L Anti-afamin antibody N14, Fab fragment, light chain 10090
761 1Q9W 1 A, C S45-18 Fab (IgG1k) light chain Fab1 Light chain kappa 10090
762 1Q9W 2 B, D S45-18 Fab (IgG1k) heavy chain Fab1 Heavy chain g1 10090
763 6P7H 1 B Antibody DF2F-b.04 light chain 9479
764 6P7H 2 A Antibody DF2F-b.04 heavy chain 9479
765 4P3C 1 H Heavy Chain Fab fragment of antibody LEM-2/15 MT1-MMP V-B loop 10090
766 4P3C 2 L Light Chain Fab fragment of antibody LEM-2/15 10090
767 1L7I 1 L chimera of Fab2C4: "humanized" murine monoclonal antibody The chimera consists of the human Ig and the original murine sequence light chain (residues 1-214) 9606
768 1L7I 2 H chimera of Fab2C4: "humanized" murine monoclonal antibody The chimera consists of the human Ig and the original murine sequence heavy chain (residues 1-216) 9606
769 1JPT 1 L immunoglobulin Fab D3h44, light chain Fab fragment 9606
770 1JPT 2 H immunoglobulin Fab D3H44, heavy chain Fab fragment 9606
771 1AQK 1 L FAB B7-15A2 IMMUNOGLOBULIN HUMAN FAB FAB 9606
772 1AQK 2 H FAB B7-15A2 IMMUNOGLOBULIN HUMAN FAB FAB 9606
773 5TL5 1 L M2177 LIGHT CHAIN 10090
774 5TL5 2 H M2177 HEAVY CHAIN 10090
775 2FX7 1 L Fab 4E10 Light Chain 9606
776 2FX7 2 H Fab 4E10 Heavy Chain 9606
777 6O39 1 A Antibody F2.I Fab, Light chain 9606
778 6O39 2 B Antibody F2.I Fab, Heavy chain 9606
779 5Y9K 1 L belimumab light chain 9606
780 5Y9K 2 H belimumab heavy chain 9606
781 4DTG 1 L Humanized recombinant FAB fragment, FAB 2021, of a murine antibody, light chain 9606
782 4DTG 2 H Humanized recombinant FAB fragment, FAB 2021, of a murine antibody, heavy chain 9606
783 5CSZ 1 A, H GANTENERUMAB FAB FRAGMENT HEAVY CHAIN FAB 9606
784 5CSZ 2 B, L GANTENERUMAB FAB FRAGMENT LIGHT CHAIN FAB 9606
785 6GLW 2 C, H Fab 1D11 - Heavy chain 9844
786 6GLW 3 D, L Fab 1D11 - Light chain 9844
787 3WFH 1 A mAb Fab H fragment 10090
788 3WFH 2 B mAb Fab L fragment 10090
789 4K3D 1 H, I BOVINE ANTIBODY WITH ULTRALONG CDR H3, HEAVY CHAIN 9913
790 4K3D 2 L, M BOVINE ANTIBODY WITH ULTRALONG CDR H3, LIGHT CHAIN 9913
791 4H8W 2 H FAB HEAVY CHAIN OF ADCC AND NON-NEUTRALIZING ANTI-HIV-1 ANTIBODY N5-I5 9606
792 4H8W 3 L FAB LIGHT CHAIN OF ADCC AND NON-NEUTRALIZING ANTI-HIV-1 ANTIBODY N5-I5 9606
793 3HNT 1 H CS-35 Fab Heavy Chain Heavy Chain 10090
794 3HNT 2 L CS-35 Fab Light Chain Light Chain 10090
795 6GKU 2 H Fab 6F5 - Heavy Chain 9844
796 6GKU 3 L Fab 6F5 - Light chain 9844
797 1WEJ 1 L E8 ANTIBODY IGG1 KAPPA MOUSE MONOCLONAL ANTIBODY FAB 10090
798 1WEJ 2 H E8 ANTIBODY IGG1 KAPPA MOUSE MONOCLONAL ANTIBODY FAB 10090
799 5VPG 2 C FAB 4C1 - LIGHT CHAIN 10090
800 5VPG 3 D FAB 4C1 - HEAVY CHAIN 10090
801 5HI4 2 C, H CAT-2000 FAB heavy chain 9606
802 5HI4 3 D, L CAT-2000 FAB light chain 9606
803 5NUZ 1 A, H eOD01 heavy chain Fab fragment (domains: variable heavy and constant heavy 1) Fab fragment (domains: variable heavy and constant heavy 1) 10090
804 5NUZ 2 B, L eOD01 light chain Fab fragment (domains: variable light and constant light) Fab fragment (domains: variable light and constant light) 10090
805 6QKD 1 H, I, J, K FAB HEAVY CHAIN 9844
806 6QKD 2 L, M, O, T FAB LIGHT CHAIN 9844
807 5FCU 2 H JR4 FAB HEAVY CHAIN 9544
808 5FCU 3 L JR4 FAB LIGHT CHAIN 9544
809 3RVW 2 C 4C1 - light chain 10090
810 3RVW 3 D 4C1 - heavy chain 10090
811 5DD3 1 H ANTI-HIV ANTIBODY DH570.4 FAB HEAVY CHAIN 9544
812 5DD3 2 L ANTI-HIV ANTIBODY DH570.4 FAB LIGHT CHAIN 9544
813 5XKU 2 B HNIgGA6 light chain 9606
814 5XKU 3 C HNIgGA6 heavy chain 9606
815 3D85 1 A FAB of antibody 7G10, light chain light chain 9606
816 3D85 2 B FAB of antibody 7G10, heavy chain heavy chain 9606
817 4Z95 1 H S1-15 Fab (IgG2b) heavy chain 10090
818 4Z95 2 L S1-15 Fab (IgG2b) light chain 10090
819 5HI5 2 C, H CAT-2000 FAB heavy chain 9606
820 5HI5 3 D, L CAT-2000 light chain 9606
821 5JO5 1 A, C, E, H 10E8 gHV 9606
822 5JO5 2 B, D, F, L 10E8 gLV 9606
823 5L9D 1 H MOUSE ANTIBODY FAB FRAGMENT, IGG1-KAPPA HEAVY CHAIN 10090
824 5L9D 2 L MOUSE ANTIBODY FAB FRAGMENT, IGG1-KAPPA LIGHT CHAIN 10090
825 5CCK 1 H Antibody 3BC315 Fab heavy chain 9606
826 5CCK 2 L Antibody 3BC315 Fab light chain 9606
827 6GXX 1 H FAB 1D9 heavy chain 10090
828 6GXX 2 L FAB 1D9 light chain 10090
829 6JP7 1 H immunoglobulin Fab heavy chain 9606
830 6JP7 2 L immunoglobulin Fab light chain 9606
831 5I76 1 A, C FM318_light_chain 1383439
832 5I76 2 B, D FM318_heavy_cahin 1383439
833 1KCV 1 L PC282 IMMUNOGLOBULIN light chain 10090
834 1KCV 2 H PC282 IMMUNOGLOBULIN heavy chain 10090
835 1FLR 1 L 4-4-20 (IG*G2A=KAPPA=) FAB FRAGMENT 10090
836 1FLR 2 H 4-4-20 (IG*G2A=KAPPA=) FAB FRAGMENT 10090
837 6MTT 1 L Antibody VRC46.01 Fb light chain 9606
838 6MTT 2 H Antibody VRC46.01 Fab heavy chain 9606
839 5I18 1 L FAB LIGHT CHAIN 9606
840 5I18 2 H FAB HEAVY CHAIN 9606
841 6QB3 2 X scFv55 9606
842 4JN1 1 H anti-dabigatran Fab1, heavy chain 10090
843 4JN1 2 L anti-dabigatran Fab1, light chain 10090
844 6UGS 1 A, H Infliximab (Remicade) Fab Heavy Chain 9606
845 6UGS 2 B, L Infliximab (Remicade) Fab Light Chain 9606
846 4P3D 1 A, H Heavy Chain Fab fragment of antibody LEM-2/15 10090
847 4P3D 2 B, L Light Chain Fab fragment of antibody LEM-2/15 10090
848 4G5Z 1 H canakinumab antibody fragment heavy chain 9606
849 4G5Z 2 L canakinumab antibody fragment light chain 9606
850 6HKG 1 A FISW84 Fab Fragment Heavy Chain 9606
851 6HKG 2 B FISW84 Fab Fragment Light Chain 9606
852 6HKG 3 C FISW84 Fab Fragment Heavy Chain 9606
853 6SF6 1 A, H COMP-reactive monoclonal antibody 15A Fab fragment, heavy chain 10090
854 6SF6 2 B, L COMP-reactive monoclonal antibody 15A Fab fragment, light chain 10090
855 3TNM 1 A, H Fab heavy chain of human anti-HIV-1 Env antibody A32 9606
856 3TNM 2 B, L Fab light chain of human anti-HIV-1 Env antibody A32 9606
857 2OK0 2 L Fab ED10 light chain 10090
858 2OK0 3 H Fab ED10 heavy chain 10090
859 6P4C 1 L HyHEL10 Fab light chain 10090
860 6P4C 2 H HyHEL10 Fab heavy chain 10090
861 3SOB 1 L antibody light chain 9606
862 3SOB 3 H antibody heavy chain 9606
863 6UG8 1 L ch28/11 Fab light chain 10090
864 6UG8 2 H ch28/11 Fab heavy chain 10090
865 6B5M 1 H CIS43 Fab Heavy chain 9606
866 6B5M 2 L CIS43 Fab Light chain 9606
867 5AWN 1 H Heavy chain of 3BC176 Fab 9606
868 5AWN 2 L Light chain of 3BC176 Fab 9606
869 4ZFO 2 L J22.9-xi Fab, Light Chain Fab Light Chain fragment of anti-BCMA antibody J22.9-xi 10090
870 4ZFO 3 A, H J22.9-xi Fab, Heavy Chain Fab Heavy Chain fragment of anti-BCMA antibody J22.9-xi 10090
871 4ZFO 4 B J22.9-xi Fab, Light Chain Fab Light Chain fragment of anti-BCMA antibody J22.9-xi 10090
872 4G6M 2 H heavy chain of gevokizumab antibody binding fragment 10090
873 4G6M 3 L light chain of gevokizumab antibody binding fragment 10090
874 5DR5 1 H AbD09097 Fab heavy chain The Fab heavy chain contains a C-terminal Myc- and hexahistidine extension preceded by thrombin peptidase recognition sequence to facilitate detection and purification 9606
875 5DR5 2 L AbD09097 Fab light chain 9606
876 6MG5 1 A, B Light chain JTO 9606
877 2IH3 1 A FAB Heavy Chain 10090
878 2IH3 2 B FAB Light Chain 10090
879 4KQ3 1 L CNTO3186 light chain Fab 9606
880 4KQ3 2 H CNTO3186 heavy chain Fab 9606
881 6AQ7 2 H POM6 FAB Heavy CHAIN 10090
882 6AQ7 3 L POM6 FAB light CHAIN 10090
883 4JFX 1 A, L Fab light chain 9606
884 4JFX 2 B, H Fab heavy chain 9606
885 3SGE 1 I, L Light Chain 10090
886 3SGE 2 H, J Heavy Chain 10090
887 1BM3 1 L IMMUNOGLOBULIN OPG2 FAB, CONSTANT DOMAIN CONSTANT DOMAIN 10090
888 1BM3 2 H IMMUNOGLOBULIN OPG2 FAB, VARIABLE DOMAIN VARIABLE DOMAIN 10090
889 4TUJ 1 A, C Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
890 4TUJ 2 B, D Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
891 2VXQ 2 H FAB H CHAIN OF THE FAB FRAGMENT COMPOSED OF THE IGE VARIABLE DOMAIN AND IGG CONSTANT DOMAIN 9606
892 2VXQ 3 L FAB L CHAIN OF THE FAB FRAGMENT COMPOSED OF THE IGE VARIABLE DOMAIN AND IGG CONSTANT DOMAIN 9606
893 2XWT 1 A THYROID BLOCKING HUMAN AUTOANTIBODY K1-70 HEAVY CHAIN FAB FRAGMENT HEAVY CHAIN, RESIDUES 1-229 9606
894 2XWT 2 B THYROID BLOCKING HUMAN AUTOANTIBODY K1-70 LIGHT CHAIN FAB FRAGMENT LIGHT CHAIN, RESIDUES 1-213 9606
895 5FHB 1 H Antibody 100 Fab heavy chain 9606
896 5FHB 2 L Antibody 100 Fab light chain 9606
897 3HZM 1 A S73-2 Fab (IgG1k) light chain 10090
898 3HZM 2 B S73-2 Fab (IgG1k) heavy chain 10090
899 1JGU 1 L Antibody Light Chain 10090
900 1JGU 2 H Antibody Heavy Chain 10090
901 4I77 1 H Lebrikizumab heavy chain Fab 9606
902 4I77 2 L Lebrikizumab light chain Fab 9606
903 4OCR 1 L CAP256-VRC26.01 light chain Fab 9606
904 4OCR 2 H CAP256-VRC26.01 heavy chain Fab 9606
905 4O4Y 1 L 2095-2 light chain SEE REMARK 999 9986
906 4O4Y 2 H 2095-2 heavy chain 9986
907 5OBF 1 H fAb Heavy chain 10090
908 5OBF 2 L fAb Light chain 10090
909 6QNK 1 A, C FAB light chain 10090
910 6QNK 2 B, D FAB heavy chain 10090
911 5LGH 1 H MOUSE ANTIBODY FAB FRAGMENT, IGG1-KAPPA HEAVY CHAIN IGG1-KAPPA HEAVY CHAIN, 1-214 10090
912 5LGH 2 L MOUSE ANTIBODY FAB FRAGMENT, IGG1-KAPPA LIGHT CHAIN IGG1-KAPPA LIGHT CHAIN, 1-214 10090
913 1UZ8 1 A, L IGG FAB (IGG3, KAPPA) LIGHT CHAIN 291-2G3-A FAB FRAGMENT LIGHT CHAIN, RESIDUES 1-212 10090
914 1UZ8 2 B, H IGG FAB (IGG3, KAPPA) HEAVY CHAIN 291-2G3-A FAB FRAGMENT HEAVY CHAIN, RESIDUES 1-213 10090
915 1DQQ 1 A, C ANTI-LYSOZYME ANTIBODY HYHEL-63 (LIGHT CHAIN) FAB FRAGMENT 10090
916 1DQQ 2 B, D ANTI-LYSOZYME ANTIBODY HYHEL-63 (HEAVY CHAIN) FAB FRAGMENT 10090
917 5L7X 1 H Mouse Antibody Fab Fragment, IgG1-kappa Heavy Chain IgG1-kappa heavy chain, 1-214 10090
918 5L7X 2 L Mouse Antibody Fab Fragment, IgG1-kappa Light Chain IgG1-kappa light chain, 1-214 10090
919 5V6M 1 L Light chain of Fab fragment of rabbit anti-HIV1 gp120 V3 mAb 10A3 9986
920 5V6M 2 H Heavy chain of Fab fragment of rabbit anti-HIV1 gp120 V3 mAb 10A3 9986
921 5MHE 1 L Fab-fragment 10090
922 5MHE 2 H Fab-fragment 10090
923 5YFI 1 L Light chain of Fab fragment 10090
924 5YFI 2 H Heavy chain of Fab fragment 10090
925 4GLR 2 H, J anti-ptau heavy chain heavy chain 9031
926 4GLR 3 I, K anti-ptau light chain light chain 9031
927 5WK3 1 P, R, T, V M116 LIGHT CHAIN 9606
928 5WK3 2 Q, S, U, W M116 HEAVY CHAIN FD 9606
929 6MTR 1 H Antibody VRC43.01 Fab heavy chain 9606
930 6MTR 2 L Antibody VRC43.01 Fab light chain 9606
931 4HJG 1 A Trastuzumab light chain 9606
932 4HJG 2 B Trastuzumab heavy chain 9606
933 5OWP 1 H Ig heavy chain V-III region J606,Ig lambda-1 chain V region H2020 10090
934 4M43 1 L Fragment antigen-binding 523-11 light chain 10090
935 4M43 2 H Fragment antigen-binding 523-11 heavy chain 10090
936 5I30 1 L Fab PL-2 light chain 10090
937 5I30 2 H Fab PL-2 heavy chain 10090
938 3HC0 1 A, H IMMUNOGLOBULIN IGG1 FAB, LIGHT CHAIN 9606
939 3HC0 2 B, L IMMUNOGLOBULIN IGG1 FAB, HEAVY CHAIN 9606
940 3BKC 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090
941 3BKC 2 H WO2 IgG2a Fab fragment Heavy Chain 10090
942 6CT7 1 B, L BIIB054 Fab light chain 9606
943 6CT7 2 A, H BIIB054 Fab heavy chain 9606
944 3FN0 1 L Fab Z13e1 light chain 9606
945 3FN0 2 H Fab Z13e1 heavy chain 9606
946 5X5X 1 H Fd chain of anti-osteocalcin antibody KTM219 10090
947 5X5X 2 L L chain of anti-osteocalcin antibody KTM219 10090
948 4YHI 1 A, H aDabi-Fab2a heavy chain 9606
949 4YHI 2 B, L aDabi-Fab2a light chain